Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A man developed skin issues from cancer medication, which improved with specific treatments.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

These new skin treatments are safer and more effective with minimal side effects.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.